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Abstract Intracochlear schwannoma is a rare, treatable,
cause of unilateral hearing loss. Due to the small size,
position, and variable clinical and imaging features, diag-
nosis presents a significant challenge and is often delayed.
We present a case of a patient with an intracochlear
schwannoma presenting as a diffuse enhancement of the
cochlea, mimicking an infectious or inflammatory process.
The absence of focal nodularity in this lesion on multiple
high-resolution MRI examinations led to a delay of over 3
years from the patient’s initial presentation to surgical
diagnosis. Clinical history and examination, imaging fea-
tures, pathologic findings, and surgical management
options are described.
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Introduction
Eighth cranial nerve schwannomas are benign tumors that
are more likely to occur in the internal auditory canal
(IAC) or in the cerebellopontine angle (CPA) cistern than
within the cochlea. Although, most schwannomas are
sporadic, they may be associated with Neurofibromatosis
Type II [1]. Intracochlear schwannomas are a rare cause of
unilateral hearing loss, with fewer than 80 cases reported in
the literature. Within the labyrinth, intravestibular sch-
wannomas are more common than intracochlear schwan-
nomas [2].
Histologically, intracochlear schwannoma is identical to
other schwannomas, apart from their location [3]. These
lesions are composed of schwann cells and tend to occur in
the modiolus and the basal turn of the cochlea along the
path of spiral ganglion dendrites [4].
Typically, intracochlear schwannomas present as focal
nodular enhancing lesions. We present a case of an in-
tracochlear schwannoma demonstrating atypical imaging
features on MRI, contributing to a delay in diagnosis and
treatment. A high clinical index of suspicion is necessary
for diagnosis and treatment.
Case report
A 33-year-old woman presented with 3 years of progres-
sively worsening left-sided hearing loss, aural fullness, and
intermittent vertigo. She denied tinnitus, ototoxic expo-
sures, trauma, and past otitis media.
MRI of the internal auditory canals (IACs) performed on
a 1.5 T scanner showed a diffuse enhancement of the left
cochlea on T1 post-gadolinium images (Fig. 1). Axial 3D
CISS images showed no evidence of a focal nodular lesion.
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The differential diagnosis at that time included viral, bac-
terial, and autoimmune phenomena. Short-term follow-up
MRIs showed a qualitative decrease in the degree of
enhancement, and the acute process causing these MRI
changes was thought to have improved.
The patient presented 3 years later with worsening
symptoms. Repeat MRI, this time performed on a 3 T
scanner, again showed smooth diffuse enhancement of all
three half-turns of the cochlea (Fig. 2). Steady-state
imaging continued to show no evidence of a focal nodular
lesion (Fig. 3). The patient’s neurotologic exam was within
normal limits. Audiologic examination revealed normal
hearing in the right ear and moderate-to-severe sensori-
neural hearing loss in the left ear with a speech reception
threshold of 45 dB and word discrimination score (WRS)
of 44%. Electronystagmography demonstrated a left-sided
significant 40% caloric paresis. Repeated audiologic exam
several months later demonstrated stable hearing thresh-
olds, but a worsening WRS of 8%. Due to the lack of
serviceable hearing and intractable vertigo, the patient
underwent left transmastoid labyrinthectomy with a bone-
anchored hearing aid (BAHA) placement.
At surgery, a mass (dimensions 0.4 9 0.3 9 0.1 cm)
was found to be confined to the labyrinth and was removed
as part of the labyrinthectomy. On pathology, a schwan-
noma was found arising from within the cochlea. The
lesion consisted of schwann cells appearing as spindle cell
proliferation, and the S100 marker was positive on
immunohistochemical staining. Verocay bodies, which
consist of a group of fusiform cells arranged in whorls or
palisades, were also evident (Fig. 4).
Discussion
Intracochlear schwannoma was first described in 1917 [5],
using archival human temporal bone specimens. This
tumor often presents with non-specific audiovestibular
symptoms. Hearing loss is the most common presenting
symptom. Although the majority of patients present with
progressive hearing loss, as in our case, 31% of patients
with intralabyrinthine schwannomas have sudden sensori-
neural hearing loss [1]. Other symptoms include tinnitus,
vertigo, imbalance, and aural fullness. Diagnosis of in-
tracochlear schwannoma is difficult and often delayed
because these presenting symptoms are shared with other
otologic diseases, particularly Meniere’s disease. In one
series of 19 patients, the mean delay from the onset of
symptoms to diagnosis was 11 years [6].
Although auditory brainstem response (ABR) testing is
highly sensitive for schwannomas larger than 1 cm, it is
inferior to gadolinium-enhanced MRI, which is the gold
standard for diagnosis [7]. In one study of intralabyrinthine
schwannomas, MRI was diagnostic in 96% of patients (one
patient had an incidental finding of intracochlear schwan-
noma at cochlear implant surgery) [1].
Current MRI evaluation of the inner ear includes axial
and coronal thin-section gadolinium-enhanced sequences
to detect the presence of an enhancing lesion as well as a
steady-state free precession sequence (SSFP, also known as
FIESTA or CISS) for improved spatial resolution.
Although MRI is useful in making the diagnosis, it too, is
limited by tumor size. Small intralabyrinthine lesions may
be particularly difficult to see on MRI, and may be seen
only in retrospect [8].
Fig. 1 Axial (top) and coronal (bottom) post-contrast T1-weighted
images (obtained on a 1.5 T Siemens Sonata scanner) show diffuse
enhancement of the left cochlea. There is no abnormal enhancement
of the left internal auditory canal or vestibule
Fig. 2 Axial (top) and coronal (bottom) post-contrast images
obtained on a 3 T Siemens Verio scanner continue to show faint
diffuse enhancement of all turns of the left cochlea
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MRI is usually ordered when asymmetric hearing loss
raises the question of a possible acoustic neuroma. How-
ever, the expensive use of frequent MRIs to diagnose in-
tracochlear schwannoma is a concern, especially as many
initial screening scans are negative. Some authors have
suggested more stringent criteria for obtaining MRIs to
diminish these costs [9].
Once diagnosed, not all the patients with intracochlear
schwannomas require surgery; the decision for treatment
depends on size and extent of tumor as well as patient
symptoms [7]. Large tumors with extra-labyrinthine
extension usually undergo surgical treatment or stereotac-
tic-guided radiotherapy. In patients with small tumors and
serviceable hearing, conservative management with repeat
MRIs to follow tumor growth may be appropriate [10].
When patients have small tumors without useful hearing
and when vestibular symptoms indicate the need for
treatment, as in our case, surgery is planned. Both trans-
labyrinthine and transotic approaches have been described;
the transotic approach is superior for more extensive
tumors [7]. Because of the risks of surgery, some authors
advocate conservative management whenever possible: in
his series from 1992 to 2002, Kennedy describes only 30%
of patients with intralabyrinthine schwannomas requiring
operative management [1].
Conclusion
We present an unusual appearance of an intracochlear
schwannoma. Although the vast majority of these tumors
are seen as focal nodular enhancing masses on MRI,
smooth diffuse enhancement of the cochlea does not
exclude the presence of a schwannoma. In patients with a
prolonged clinical presentation atypical for an inflamma-
tory or infectious lesion, diffuse cochlear enhancement
should not exclude the possibility of an intracochlear
schwannoma.
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